2. 您的位置
3. 首页
4. 会议论文
5. THE FIRST VACCINE AND CERVICAL CANCER SCREEN PROJECT (VACCS1): COMBINING THE HPV-VACCINE AND SELF-SC

THE FIRST VACCINE AND CERVICAL CANCER SCREEN PROJECT (VACCS1): COMBINING THE HPV-VACCINE AND SELF-SC

来源 :The 6th Biennial Conference of Asia Oceania Research Organis | 被引量 : 0次 | 上传用户：shellyyiqiong

【摘 要】

：

Background Cervical cancer is preventable but still highly prevalent in South Africa.New strategies to implement effective primary and secondary prevention technologiesinto the developing world are ur

【作 者】

：

Dreyer G Botha MH Snyman LC Van der Merwe FH Laubscher N Visser C Bekker p Harvey J 

【机 构】

：

Gynaecological Oncology Unit,Department of Obstetrics and Gynaecology,University of Pretoria,South A

【出 处】

：

The 6th Biennial Conference of Asia Oceania Research Organis

【发表日期】

：

2014年2期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Background Cervical cancer is preventable but still highly prevalent in South Africa.New strategies to implement effective primary and secondary prevention technologiesinto the developing world are urgently needed.

其他文献

ADDRESSING ISSUES OF SCREENING AND TREATMENT OF HIV-INFECTED WOMEN IN RESOURCE LIMITED SETTINGS

Invasive cervical cancer and high grade precancerous cervical lesions are more common among HIV-seropositive than HIV-seronegative women, with rates of cervical disease notably higher among HIV-seropo

会议

Association of antiestrogen use and risk of cervical neoplasia in breast cancer patients

Estrogen has been proven to be necessary for cervical carcinogenesis by transgenic studies, but its role in human cervical carcinogenesis remains unclear.

会议

Genetic susceptibility to HPV infection and cervical carcinogenesis

Cervical cancer is strongly associated with the infection by oncogenic forms of human papillomavirus (HPV).

会议

Epidemiology of cervical cancer in Asia-Pacific

Cancer is now the leading cause of death worldwide across all ages and in the premature age range (ages 30-69).

会议

Epidemiology of HPV Infection and Cervical Cancer in China

Studies shown that HPV prevalence was ranged from 10％ to 25％ in Chinese women without cervical abnormalities, and significant infection prevalences were found in CIN, cancer in situ and cancers (68.8％

会议

Tobacco Use as a Risk Factor for Cervical Cancer

The role of cigarette smoking as acause of cervical cancer wasslow to be appreciated and provides an important illustration of the role of knowledge about biological mechanisms in causal inferences fr

会议

Future HPV Vaccines and Considerations for Implementation in Developing Countries

Human papillomavirus (HPV), the most common sexually transmitted virus, and its associated diseases continue to cause significant morbidity and mortality in over 600 million infected individuals.Major

会议

Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies again

A pseudovirion-based neutralisation assay (PBNA) has been considered the gold standard for measuring specific antibody responses against human papillomavirus (HPV).

会议

HPV VACCINES: Population impact of HPV vaccination: evidence from a National program

Objective:To describe the most up-to-date data on the population impact of a school-based national programme of the quadrivalent (6, 11, 16, 18) vaccine (GARDASILTM) in Australia.Methods and Conclusio

会议

Comparison of HPV genotypes and viral load between different sites of the entire genital tract the s

Objectives: To compare the consistency of HPV genotype and viral loads among different sites within the female genital tract, and to correlate these with clinical outcomes.

会议